“…Results from others (Filipek et al, 2002b;Wu et al, 2003) and our studies suggest that phosphorylation and nuclear translocation are crucial for the function of SIP. We further demonstrate that phosphorylation at the Ser141 residue, the N-terminal region (aa 1-43) and the putative NLS region (aa 143-159) are crucial for nuclear translocation of SIP.…”
Section: Discussionsupporting
confidence: 69%
“…It has been revealed that SIP is phosphorylated by PKC in vitro (Filipek et al, 2002b) and curcumin activates PKC in a membrane-dependent and calciumregulated manner (Mahmmoud, 2007). In our study, both curcumin and PKC activator (PMA) cause SIP phosphorylation in MOLT-4 but not MOLT-4/AraG cells.…”
Section: Discussionmentioning
confidence: 46%
“…These data suggest that other modifications, besides the total amount of SIP protein, also contribute to the intensity change of SIP spot on 2D gel. It has been demonstrated that SIP is phosphorylated in unknown serine residues in neuroblastoma cells upon KCl or retinoic acid treatment (Filipek et al, 2002b;Wu et al, 2003). Furthermore, phosphorylation may cause changes in both isoelectric point and molecular weight of protein and therefore lead to the relocation of protein spots on 2D gel.…”
Section: Resultsmentioning
confidence: 99%
“…To verify whether the observed intensity change in SIP spot was due to the altered phosphorylation pattern of SIP, the whole cell extracts from MOLT-4 or MOLT-4/AraG treated with curcumin or DMSO were immunoprecipitated with anti-SIP, followed by immunoblotting with anti-phosphoserine antibody (Figure 2c). Cells treated with PMA, a protein kinase C (PKC) activator proved to induce SIP phosphorylation (Filipek et al, 2002b), served as a positive control. Interestingly, similar to PMA-treated cells, a strong band indicating phosphorylation in the serine residues of SIP was detected in curcumin-exposed MOLT-4 cells (Figure 2c, bottom left panel).…”
Section: Resultsmentioning
confidence: 99%
“…We next examined whether the cellular localization of SIP changed upon curcumin treatment, considering that it underwent both nuclear translocation and phosphorylation in KCl-or retinoic acid-treated cells (Filipek et al, 2002b;Wu et al, 2003). Using immunofluorescence staining, we found that curcumin exposure caused a significant translocation of endogenous SIP from the cytoplasm to nucleus in both MOLT-4 and MOLT-4/TG but not in MOLT-4/AraG cells ( Figure 3a).…”
The mechanism underlying curcumin (diferuloylmethane) resistance is still largely unknown. Here we employed proteomic approach to identify the Siah-interacting protein (SIP) as a candidate for detailed study, because the spot intensity of SIP on a two-dimensional gel displayed 70-90% reduction in curcumin-sensitive cells, but remained unchanged in curcumin-resistant sublines, after curcumin treatment. Both gain-and loss-of-function studies revealed that SIP promoted curcumin-induced apoptosis. Moreover, SIP underwent phosphorylation and nuclear translocation in curcumin-sensitive but not resistant cells, upon curcumin exposure. The nuclear translocation of SIP was remarkably impaired when a putative nuclear localization sequence (NLS, amino acid (aa) 143-159) was deleted or the serine 141 was mutated into alanine, whereas truncation of the N-terminal region (aa 1-43) obviously increased the nuclear import of SIP. In accordance with their nuclear localization, N-terminal truncation significantly enhanced the proapoptotic effect of SIP, whereas NLS deletion or Ser141Ala mutation attenuated the apoptosis-promoting activity of both wildtype-and N-terminal truncated-SIP. These data suggest that SIP plays a role in apoptosis and curcumin resistance, and the function of SIP may be regulated by different motifs, such as the NLS, N-terminal region and serine 141. Our findings provide new insights into the biological significance of SIP and the mechanisms of drug resistance.
“…Results from others (Filipek et al, 2002b;Wu et al, 2003) and our studies suggest that phosphorylation and nuclear translocation are crucial for the function of SIP. We further demonstrate that phosphorylation at the Ser141 residue, the N-terminal region (aa 1-43) and the putative NLS region (aa 143-159) are crucial for nuclear translocation of SIP.…”
Section: Discussionsupporting
confidence: 69%
“…It has been revealed that SIP is phosphorylated by PKC in vitro (Filipek et al, 2002b) and curcumin activates PKC in a membrane-dependent and calciumregulated manner (Mahmmoud, 2007). In our study, both curcumin and PKC activator (PMA) cause SIP phosphorylation in MOLT-4 but not MOLT-4/AraG cells.…”
Section: Discussionmentioning
confidence: 46%
“…These data suggest that other modifications, besides the total amount of SIP protein, also contribute to the intensity change of SIP spot on 2D gel. It has been demonstrated that SIP is phosphorylated in unknown serine residues in neuroblastoma cells upon KCl or retinoic acid treatment (Filipek et al, 2002b;Wu et al, 2003). Furthermore, phosphorylation may cause changes in both isoelectric point and molecular weight of protein and therefore lead to the relocation of protein spots on 2D gel.…”
Section: Resultsmentioning
confidence: 99%
“…To verify whether the observed intensity change in SIP spot was due to the altered phosphorylation pattern of SIP, the whole cell extracts from MOLT-4 or MOLT-4/AraG treated with curcumin or DMSO were immunoprecipitated with anti-SIP, followed by immunoblotting with anti-phosphoserine antibody (Figure 2c). Cells treated with PMA, a protein kinase C (PKC) activator proved to induce SIP phosphorylation (Filipek et al, 2002b), served as a positive control. Interestingly, similar to PMA-treated cells, a strong band indicating phosphorylation in the serine residues of SIP was detected in curcumin-exposed MOLT-4 cells (Figure 2c, bottom left panel).…”
Section: Resultsmentioning
confidence: 99%
“…We next examined whether the cellular localization of SIP changed upon curcumin treatment, considering that it underwent both nuclear translocation and phosphorylation in KCl-or retinoic acid-treated cells (Filipek et al, 2002b;Wu et al, 2003). Using immunofluorescence staining, we found that curcumin exposure caused a significant translocation of endogenous SIP from the cytoplasm to nucleus in both MOLT-4 and MOLT-4/TG but not in MOLT-4/AraG cells ( Figure 3a).…”
The mechanism underlying curcumin (diferuloylmethane) resistance is still largely unknown. Here we employed proteomic approach to identify the Siah-interacting protein (SIP) as a candidate for detailed study, because the spot intensity of SIP on a two-dimensional gel displayed 70-90% reduction in curcumin-sensitive cells, but remained unchanged in curcumin-resistant sublines, after curcumin treatment. Both gain-and loss-of-function studies revealed that SIP promoted curcumin-induced apoptosis. Moreover, SIP underwent phosphorylation and nuclear translocation in curcumin-sensitive but not resistant cells, upon curcumin exposure. The nuclear translocation of SIP was remarkably impaired when a putative nuclear localization sequence (NLS, amino acid (aa) 143-159) was deleted or the serine 141 was mutated into alanine, whereas truncation of the N-terminal region (aa 1-43) obviously increased the nuclear import of SIP. In accordance with their nuclear localization, N-terminal truncation significantly enhanced the proapoptotic effect of SIP, whereas NLS deletion or Ser141Ala mutation attenuated the apoptosis-promoting activity of both wildtype-and N-terminal truncated-SIP. These data suggest that SIP plays a role in apoptosis and curcumin resistance, and the function of SIP may be regulated by different motifs, such as the NLS, N-terminal region and serine 141. Our findings provide new insights into the biological significance of SIP and the mechanisms of drug resistance.
Calcyclin-binding protein or Siah-1-interacting protein (CacyBP/SIP) was previously reported to promote the proliferation of glioma cells. However, the effect of CacyBP/SIP on apoptosis of glioma is poorly understood. Here, our study shows that CacyBP/SIP plays a role in inhibiting doxorubicin (DOX) induced apoptosis of glioma cells U251 and U87. Overexpression of CacyBP/SIP obviously suppressed the DOX-induced cell apoptosis. On the contrary, silencing of CacyBP/SIP significantly promoted it. Further investigation indicated that inhibition of apoptosis by CacyBP/SIP was relevant to its nuclear translocation in response to the DOX treatment. Importantly, we found that the level of p-ERK1/2 in nuclei was related to the nuclear accumulation of CacyBP/SIP. Finally, the role of CacyBP/SIP was confirmed in vivo in a mouse model with the cell line stably silencing CacyBP/SIP. Taken together, our results suggest that CacyBP/SIP plays an important role in inhibiting apoptosis of glioma cells which might be mediated by ERK1/2 signaling pathway, which will provide some guidance for the treatment of glioma. V C 2016 IUBMB Life, 68(3): [211][212][213][214][215][216][217][218][219] 2016
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.